User menu

Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study.

Bibliographic reference Kalincik, Tomas ; Brown, J William L ; Robertson, Neil ; Willis, Mark ; Scolding, Neil ; et. al. Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study.. In: The Lancet Neurology, Vol. 16, no.4, p. 271-281 (2017)
Permanent URL http://hdl.handle.net/2078.1/185969